Statistics for Peptide Receptor Radionuclide Therapy with 177 Lu-DOTA-TATE As a Promising Treatment of Malignant Insulinoma: a Series of Case Reports and Literature Review
Total visits
| views | |
|---|---|
| Peptide Receptor Radionuclide Therapy with 177 Lu-DOTA-TATE As a Promising Treatment of Malignant Insulinoma: a Series of Case Reports and Literature Review | 45 |
Total visits per month
| views | |
|---|---|
| November 2024 | 6 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| J Endocrinol Invest 2019 249.pdf(legacy) | 65 |
| J Endocrinol Invest 2019 249.pdf | 2 |
| Graephes Arch Clin exp Opht 2017 1827.pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| United States | 19 |
| Australia | 8 |
| China | 6 |
| India | 5 |
| Argentina | 2 |
| Chile | 2 |
| Japan | 1 |
| Mongolia | 1 |
| Ukraine | 1 |